Coverity Development Testing Ensures Software Quality in Drager’s Life-Saving Medical Devices
SAN FRANCISCO, Feb. 28, 2012 /PRNewswire/ — Coverity, Inc., the development testing leader, announced today that Drager Medical GmbH, a leading international provider of medical devices and technology, has successfully deployed Coverity® Static Analysis as its development testing solution. Software code testing via static analysis is an FDA recommended testing activity according to the FDA General Principles of Software Validation guidance. With Coverity Static Analysis, Drager Medical is enabled to find hard-to-spot yet critical software defects earlier in the software development lifecycle, as the code is being written, when it is easiest and least expensive to find and fix. Such testing helps ensure the quality of software code in a broad set of life-saving medical devices and thus helps Drager meet FDA guidelines for software verification.
Drager delivers critical equipment to global healthcare markets to enable emergency response, bring about faster patient recoveries, and allow hospitals to more affordably access cutting-edge medical treatments. Its guiding principle is “Technology for Life”, which means more than merely technical excellence. It also means assuming responsibility for the lives of those who use Drager products and depend on them. From medical ventilation systems and monitoring equipment to anesthesia workspaces and devices for neonatal care, Drager needs to ensure that the embedded software in its medical devices is of the highest quality and does not impact patient safety.
“Drager Medical creates technology that saves lives, and we continually strive to further improve the process of safeguarding the integrity of the medical devices that the healthcare industry relies on,” commented Florian Mösch, Senior Software Engineer at Drager Medical. “A combination of defects in medical devices could cause malfunctions that may lead to serious injury of patients. Coverity helps us identify and eliminate these defects more easily.”
“Development testing complements traditional quality assurance measures to help ensure the quality, safety and security of devices people use every day,” said Jennifer Johnson, VP of Marketing at Coverity. “We are excited to be part of Drager Medical’s development process to help them continue to bring innovative and high quality products to market.”
Coverity (www.coverity.com), the development testing leader, is the trusted standard for companies that need to protect their brands and bottom lines from software failures. More than 1,100 Coverity customers use Coverity’s development testing suite of products to automatically test source code for software defects that could lead to product crashes, unexpected behavior, security breaches, or catastrophic failure. Coverity is a privately held company headquartered in San Francisco. Coverity is funded by Foundation Capital and Benchmark Capital. Follow us on Twitter or check out our blog.
SOURCE Coverity, Inc.